KLOWTissue Repair Peptide Blend (GHK-Cu · BPC-157 · TB-500 · KPV) — Scientific Guide

What is KLOW?

Le KLOWis apeptide blendresearch combining four peptides with complementary repairing and regenerative properties in a single vial. Its name is an acronym of its components, and it concentrates80 mg of active peptidesdistributed as follows:GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 / Thymosin Beta-4 (10 mg) et KPV (10 mg).

The scientific interest of KLOW does not lie in a single mechanism but in theconvergence of four distinct pathstissue repair. Whereas an isolated peptide acts on a precise lever, the blend makes it possible to study the effect of a simultaneous stimulation of angiogenesis, cell migration, collagen synthesis and inflammatory modulation.

Blend composition

Mechanisms of action

The strength of KLOW lies in the complementarity of its four components, which act on distinct but convergent pathways of tissue repair.

Angiogenesis and vascularization

Le GHK-Cuand theBPC-157stimulate the formation of new blood vessels, notably through the expression ofVEGF(Vascular Endothelial Growth Factor). TB-500 enhances this pathway by promoting the migration and proliferation of endothelial cells. The objective of the study is to improve the supply of oxygen and nutrients to damaged tissues—a step that is often critical for wound healing.

Cell migration and proliferation

Le TB-500It regulates G-actin polymerization, facilitating the migration of repair cells (fibroblasts, keratinocytes, endothelial cells) to damaged areas. This cell mobility is a prerequisite for the formation of granulation tissue and wound closure.

Matrix synthesis and collagen

Le GHK-Cuactivates fibroblasts and stimulates the production ofcollagen (types I and III), elastin and glycosaminoglycans. It is this property that makes it one of the most studied peptides for the quality of the reconstructed extracellular matrix, and not simply the speed of closure of a lesion.

Modulation of inflammation

Le KPVinhibits pro-inflammatory pathways (in particularNF-κB) and reduces cytokine production. In a repair-oriented blend, its function is to maintain inflammation within a physiological window: sufficient to initiate repair, but limited to prevent chronic tissue damage.

Synergy of the four components

The research hypothesis behind KLOW is that these four peptides together cover most of the steps in the tissue repair cascade, whereas each one taken in isolation only covers a part of it.

KLOW Technical Specifications

Reconstruction and manipulation in research

KLOW reconstitutes like a classic lyophilized peptide, at thebacteriostatic waterThe volume of solvent is chosen according to the desired working concentration: a larger volume facilitates the taking of small doses, but dilutes the solution. Since the flask must remain intact, dissolution is carried out by letting the water run down the side, without vigorous shaking, to preserve the peptides.

Since the blend is a fixed combination, the ratio between the four components remains constant regardless of the sample: GHK-Cu cannot be isolated from BPC-157, for example. For protocols requiring independent measurement of a component, isolated peptides remain the appropriate format.

Limitations and state of research

As with its components taken separately, the available data on KLOW and its peptides are almost exclusivelypreclinical(rodents, cell models):

• Lack of large-scale randomized clinical trials on the blend as such
• The data come primarily from studies on each isolated peptide, and not on their fixed combination.
• The pharmacokinetic interactions between the four components administered together remain poorly characterized.
• Pro-angiogenic mechanisms theoretically to be monitored in neoplastic contexts